Retinal Imaging in Patients With Inherited Retinal Degenerations

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Oct 2028 to Oct 1, 2028
    • Study completion date: Nov 2028 to Nov 1, 2028
    v23
  2. Start date: Nov 2005 to Nov 1, 2005
    • Site contact updated
    v22
  3. Primary completion date: Oct 2023 to Oct 2028
    • Study completion date: Nov 2024 to Nov 2028
    • Site contact updated
    v21
  4. Eligibility criteria expanded, about 3 wordsv20
  5. 3 versions Re-verified since Nov 9, 2019, no change to tracked fieldsv17-v19
Show 15 earlier versionsHide 15 earlier versions
  1. Primary completion date: Oct 2017 to Oct 2023
    • Study completion date: Nov 2019 to Nov 2024
    v16
  2. Primary completion date: Oct 2016 to Oct 2017
    • Study completion date: Nov 2016 to Nov 2019
    • Site contact updated
    v15
  3. Site contact updatedv14
  4. Enrollment target: 130 to 400v13
  5. Re-verified, no change to tracked fieldsv12
  6. Primary completion date: Oct 2016v11
  7. Study Status, Conditions, Outcome Measures, Eligibilityv10
  8. Re-verified, no change to tracked fieldsv9
  9. Study completion date: Nov 2011 to Nov 2016
    • Site contact updated
    v8
  10. Site contact updatedv7
  11. Study site revised
    • Publications: 9 to 12
    v6
  12. Site contact updatedv5
  13. Site contact updatedv4
  14. Site contact updatedv3
  15. Eligibility criteria expanded, about 19 words
    • Study description shortened, about 28 words
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine whether the structure and function of the human retina can be studied with high resolution in patients with inherited retinal degenerations using the Adaptive Optics Scanning Laser Ophthalmoscope (AOSLO).
Trial Details
NCT Number NCT00254605
Lead Sponsor University of California, San Francisco
Collaborators: University of California, Berkeley
Conditions
(from sponsor)		 Retinitis Pigmentosa
Related terms Retinitis Pigmentosa
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov